ACTAVIS FDA Thursday, September 24, 2026 0.00 Neutral

FDA Approves Unknown Drug — ACTAVIS LABS FL

FDA has approved a generic drug under Application #ANDA211255 manufactured by ACTAVIS LABS FL, removing any potential generic competition for the subject product. The approval is expected to establish a new pricing standard, allowing ACTAVIS LABS FL to capitalize on the market conditions for the branded drug until patents expire.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed